Company Profile
Ikarovec Limited
11504964•Private Limited With Share Capital
Get Full Access
07/08/2018
7 years
8
7
72110
moderate risk
Company Overview
Registration, classification & business activity
Ikarovec Limited (11504964) is a private limited with share capital incorporated on 07/08/2018 (7 years old) and registered in norwich, NR47GJ. The company operates under SIC code 72110 - research and experimental development on biotechnology.
The company has an early stage pipeline of novel, multi-cistronic gene therapy products targeting diabetic macular edema (dme), age-related macular degeneration (amd, both wet and dry forms) and ocular hypertension.
Financial Overview
£3.77M
£438.8K
£3.34M
£3.10M
Key Metrics
7
Employees
8
Directors
13
Shareholders
7
Patents
Board of Directors
Innovate Grants
This company received a grant of £458740.0 for The Development Of A Novel Gene Therapy To Treat Age Related Macular Degeneration (Amd). The project started on 01/07/2020 and ended on 31/03/2023.
This company received a grant of £364850.0 for Aav Formulation Consortium - Improving Aav Stability Through Optimised Formulations And Development Of An Analytical Toolbox For Stability Characterisation. The project started on 01/05/2024 and ended on 31/03/2026.
Import / Export
Risk Assessment
moderate risk
International Score
Future Factor
excellent
Performance Rating